10
Participants
Start Date
May 15, 2019
Primary Completion Date
May 15, 2025
Study Completion Date
May 15, 2027
Abemaciclib 200 MG
Subjects will be treated with abemaciclib 200mg by mouth once every 12 hours. Dosing will be continuous and administered on a 28-day cycle
University of Pennsylvania, Philadelphia
Abramson Cancer Center at Penn Medicine
OTHER
University of Pennsylvania
OTHER
Stephen Bagley, MD, MSCE
OTHER